We are live on
!
Find out more
EA
Emerald Acquisition Portfolio holdings
AUM
$51.8B
This Fund
S&P 500
This Quarter
Est. Return
+5.73%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$51.8B
AUM Growth
-$5.97B
(-10%)
Cap. Flow
-$8.46B
Cap. Flow
% of AUM
-16.35%
Top 10 Holdings %
Top 10 Hldgs %
10.38%
Holding
3,194
New
200
Increased
788
Reduced
1,868
Closed
214
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KeyCorp
KEY
|
+$59.1M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$56.2M |
| 3 |
DD
Du Pont De Nemours E I
DD
|
+$54M |
| 4 |
Alibaba
BABA
|
+$47.2M |
| 5 |
McKesson
MCK
|
+$43.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$142M |
| 2 |
Johnson & Johnson
JNJ
|
+$133M |
| 3 |
Wells Fargo
WFC
|
+$131M |
| 4 |
TSMC
TSM
|
+$120M |
| 5 |
Corning
GLW
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.06% |
| 2 | Healthcare | 12.4% |
| 3 | Technology | 11.83% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Group 1 Automotive
GPI
$3.9B
| $355K | ﹤0.01% |
5,561
-3,761
| -40% | -$222K |
|
|
ARA
2502
DELISTED
American Renal Associates Holdings, Inc
ARA
| $353K | ﹤0.01% |
+19,305
| New | +$435K |
|
|
BCS.PRD.CL
2503
DELISTED
Barclays Bank Plc
BCS.PRD.CL
| $353K | ﹤0.01% |
13,560
+8,000
| +144% | +$209K |
|
|
ALR
2504
DELISTED
Alere Inc
ALR
| $351K | ﹤0.01% |
8,125
-9,276
| -53% | -$378K |
|
|
FNBC
2505
DELISTED
First NBC Bank Holding Company
FNBC
| $351K | ﹤0.01% |
37,220
-132,330
| -78% | -$1.92M |
|
|
CWBC
2506
Community West Bancshares
CWBC
$726M
| $350K | ﹤0.01% |
22,086
+11,999
| +119% | +$182K |
|
2507
Metallus
MTUS
$832M
| $350K | ﹤0.01% |
33,471
-53,112
| -61% | -$528K |
|
2508
Southern Copper
SCCO
$163B
| $349K | ﹤0.01% |
14,327
-27,718
| -66% | -$669K |
|
2509
Evolution Petroleum
EPM
$143M
| $347K | ﹤0.01% |
+55,273
| New | +$316K |
|
|
LORL
2510
DELISTED
Loral Space and Communications, Inc.
LORL
| $347K | ﹤0.01% |
+8,875
| New | +$321K |
|
|
GOOD
2511
Gladstone Commercial Corp
GOOD
$629M
| $346K | ﹤0.01% |
+18,532
| New | +$333K |
|
|
UHT
2512
Universal Health Realty Income Trust
UHT
$601M
| $345K | ﹤0.01% |
5,476
-455
| -8% | -$27.5K |
|
2513
CytomX Therapeutics
CTMX
$725M
| $342K | ﹤0.01% |
21,842
-21,842
| -50% | -$264K |
|
|
CMCM
2514
Cheetah Mobile
CMCM
$90.3M
| $341K | ﹤0.01% |
5,475
-5,474
| -50% | -$316K |
|
|
ATYR
2515
aTyr Pharma
ATYR
$47.8M
| $339K | ﹤0.01% |
7,601
+2,293
| +43% | +$99.1K |
|
|
CMRX
2516
DELISTED
Chimerix, Inc.
CMRX
| $339K | ﹤0.01% |
+61,204
| New | +$280K |
|
|
CPHD
2517
DELISTED
Cepheid Inc
CPHD
| $339K | ﹤0.01% |
6,437
-115,690
| -95% | -$4.61M |
|
2518
Transocean
RIG
$5.87B
| $338K | ﹤0.01% |
31,740
-516,974
| -94% | -$5.46M |
|
|
MN
2519
DELISTED
MANNING & NAPIER, INC.
MN
| $338K | ﹤0.01% |
47,604
+6,899
| +17% | +$55.3K |
|
|
DVAX
2520
DELISTED
Dynavax Technologies
DVAX
| $336K | ﹤0.01% |
32,051
-323
| -1% | -$4.64K |
|
|
IL
2521
DELISTED
IntraLinks Holdings Inc.
IL
| $335K | ﹤0.01% |
+33,345
| New | +$282K |
|
|
TNGO
2522
DELISTED
Tangoe, Inc.
TNGO
| $334K | ﹤0.01% |
40,478
-29,564
| -42% | -$254K |
|
2523
Shore Bancshares
SHBI
$765M
| $332K | ﹤0.01% |
28,248
+20,450
| +262% | +$239K |
|
|
CSRA
2524
DELISTED
CSRA Inc.
CSRA
| $332K | ﹤0.01% |
12,376
-11,166
| -47% | -$288K |
|
|
JOY
2525
DELISTED
Joy Global Inc
JOY
| $332K | ﹤0.01% |
11,957
-407,447
| -97% | -$10.8M |
|
Similar funds
SAMC
AI
JHC
EDRAMF
PRA
TH
GF
ACN
Emerald Acquisition's Q3 2016 Portfolio in Review
As of Q3 2016, Emerald Acquisition held 3,194 positions worth $51.8B, down 10% from $57.7B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Emerald Acquisition withdrew a net $8.46B in Q3 2016, closing 214 positions and reducing 1,868 holdings. Its most notable exit was EMC CORPORATION, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Emerald Acquisition opened a new position in Novo Nordisk worth $13.9M.
- Emerald Acquisition's largest Q3 2016 buy was Novo Nordisk: 666,610 shares worth $13.9M.
- Emerald Acquisition added most to KeyCorp in Q3 2016, an estimated $59.1M increase.
- Emerald Acquisition's biggest Q3 2016 reduction was Johnson & Johnson, cutting an estimated $133M.
- Emerald Acquisition fully exited EMC CORPORATION in Q3 2016, selling an estimated $142M.
- Emerald Acquisition's ten largest holdings make up 10% of its $51.8B portfolio in Q3 2016.
- Emerald Acquisition opened 200 new positions and closed 214 in Q3 2016.
- Emerald Acquisition's portfolio value fell 10% quarter-over-quarter to $51.8B.
Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.